M2 TAMs in the TME were found to inhibit apoptosis and promote resistance to 5-fluorouracil (5-FU) by secreting CXC chemokine ligand 5 (CXCL5) and activating the PI3K/AKT/mTOR signaling pathway in gastric cancer cells. This evidence concerns the gene CXCL5 and gastric cancer.